Delirium incidence and risk factors in patients undergoing non-invasive ventilation for acute respiratory failure: a multicenter observational trial.
Journal
Minerva anestesiologica
ISSN: 1827-1596
Titre abrégé: Minerva Anestesiol
Pays: Italy
ID NLM: 0375272
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
pubmed:
17
6
2022
medline:
20
10
2022
entrez:
16
6
2022
Statut:
ppublish
Résumé
Noninvasive ventilation (NIV) still has high failure rate when used for de novo acute respiratory failure (ARF). Delirium may impact the outcome, however data regarding its incidence, timing of occurrence and clinical predictors in this subset of patients are scarce. Consecutive patients with de novo ARF subjected to NIV were recruited in 10 Italian Respiratory Intensive Care Units (RICUs) and Intensive Care Units (ICUs). Demographics and clinical features, including tolerance to interface and NIV setting were recorded on admission and during stay, whereas delirium onset and type was assessed by the Confusion Assessment Method for ICU (CAM-ICU)-7 scale and Richmond Agitation Sedation Scale (RASS) twice/per day up to a week. The association between clinical variables and the occurrence of delirium and its influence on NIV failure and other clinical outcomes were analyzed. Thirty-two out of 90 enrolled patients (36%) developed delirium over seven days upon admission; median time to onset was 48 hours (24-60). Older age (OR=2.7 [1.9-9], P=0.01), the presence of cancer OR=3.7 [2-5.4], P=0.002), sepsis (OR=1.7 [1.1-3.4], P=0.01), SOFA Score (OR=1.8 [1.1-3.1], P=0.01), low tolerance to interface (OR=3.2 [2.1-5], P=0.002), use of helmet (OR=1.9 [1.2-4.3] P=0.04), and higher PRE-DELIRIC (OR=3.5 [1.3-15], P=0.03) and BORG (OR=1.7 [1.1-4.6], P=0.02] scores were significantly associated with delirium. Delirium had high risk for NIV failure (HR=3.5 95% CI: [1.4-8.6], P=0.0002) and it significantly associated with longer RICU/ICU stay and higher mortality. Delirium onset in acute hypoxic patients undergoing NIV is frequent and negatively affects the outcome. Multiple related clinical factors should be addressed early on admission to prevent the delirium-related risk of NIV failure in these patients.
Sections du résumé
BACKGROUND
Noninvasive ventilation (NIV) still has high failure rate when used for de novo acute respiratory failure (ARF). Delirium may impact the outcome, however data regarding its incidence, timing of occurrence and clinical predictors in this subset of patients are scarce.
METHODS
Consecutive patients with de novo ARF subjected to NIV were recruited in 10 Italian Respiratory Intensive Care Units (RICUs) and Intensive Care Units (ICUs). Demographics and clinical features, including tolerance to interface and NIV setting were recorded on admission and during stay, whereas delirium onset and type was assessed by the Confusion Assessment Method for ICU (CAM-ICU)-7 scale and Richmond Agitation Sedation Scale (RASS) twice/per day up to a week. The association between clinical variables and the occurrence of delirium and its influence on NIV failure and other clinical outcomes were analyzed.
RESULTS
Thirty-two out of 90 enrolled patients (36%) developed delirium over seven days upon admission; median time to onset was 48 hours (24-60). Older age (OR=2.7 [1.9-9], P=0.01), the presence of cancer OR=3.7 [2-5.4], P=0.002), sepsis (OR=1.7 [1.1-3.4], P=0.01), SOFA Score (OR=1.8 [1.1-3.1], P=0.01), low tolerance to interface (OR=3.2 [2.1-5], P=0.002), use of helmet (OR=1.9 [1.2-4.3] P=0.04), and higher PRE-DELIRIC (OR=3.5 [1.3-15], P=0.03) and BORG (OR=1.7 [1.1-4.6], P=0.02] scores were significantly associated with delirium. Delirium had high risk for NIV failure (HR=3.5 95% CI: [1.4-8.6], P=0.0002) and it significantly associated with longer RICU/ICU stay and higher mortality.
CONCLUSIONS
Delirium onset in acute hypoxic patients undergoing NIV is frequent and negatively affects the outcome. Multiple related clinical factors should be addressed early on admission to prevent the delirium-related risk of NIV failure in these patients.
Identifiants
pubmed: 35708040
pii: S0375-9393.22.16511-9
doi: 10.23736/S0375-9393.22.16511-9
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
815-826Investigateurs
Alessandro Andreani
(A)
Dario Andrisani
(D)
Serena Baroncini
(S)
Bianca Beghè
(B)
Lucio Bonazza
(L)
Elisa Boni
(E)
Giulia Bruzzi
(G)
Michele Cacciapaglia
(M)
Gaia Cappiello
(G)
Ivana Castaniere
(I)
Caterina Cerbone
(C)
Enrico Clini
(E)
Vittoria Comellini
(V)
Roberto Dongilli
(R)
Pierluigi Donatelli
(P)
Vinicio Danzi
(V)
Riccardo Fantini
(R)
Laura Falsini
(L)
Marco Feri
(M)
Filippo Gozzi
(F)
Linda Manicardi
(L)
Alessandro Marchioni
(A)
Enrico Marin
(E)
Rosita Melara
(R)
Antonio Moretti
(A)
Chiara Nani
(C)
Stefano Nava
(S)
Maria C Paonessa
(MC)
Giustino Parruti
(G)
Lara Pisani
(L)
Beniamino Praticò
(B)
Viviana Ribuffo
(V)
Marianna Sacchi
(M)
Sara Sorgentone
(S)
Antonella Spacone
(A)
Luca Tabbì
(L)
Roberto Tonelli
(R)
Fabiana Trentacosti
(F)
Morgana Vermi
(M)